Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aerobic Exercise for Endogenous Opioid Function in Chronic Pain
NCT02469077Completed
- Sponsor
- Vanderbilt University Medical Center
- Start
- Aug 2015
- Primary completion
- Sep 2019
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Vanderbilt University Medical Center. Primary endpoints: Mean of the Change in Morphine Dosage Required to Achieve 25% Reduction in Thermal Evoked Pain Responses at 6 weeks and Mean Change in 5-day Electronic Diary Ratings of Low Back Pain Intensity at 6 weeks. Started Aug 2015; status: completed.
Beyond the preview
Go deeper on NCT02469077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02469077.